Pulmonary Embolism at CT Pulmonary Angiography in Patients with COVID-19.

Journal: Radiology. Cardiothoracic imaging
Published Date:

Abstract

PURPOSE: To evaluate pulmonary embolism (PE) prevalence at CT pulmonary angiography in patients testing positive for coronavirus disease 2019 (COVID-19) and factors associated with PE severity.

Authors

  • Mark Kaminetzky
    Department of Radiology (M.K., W.M., K.F., J.S.B., G.M., J.P.K.), Department of Medicine, Division of Hematology and Medical Oncology, Laura and Isaac Perlmutter Cancer Center (D.K.), and Center for Healthcare Innovation and Delivery Science (L.I.H.), NYU Langone Health, 550 First Ave, New York, NY 10016; Division of Healthcare Delivery Science, Department of Population Health and Division of General Internal Medicine and Clinical Innovation, Department of Medicine, NYU Grossman School of Medicine, New York, NY (L.I.H.); and Garden State Urology, Wayne, NJ (A.K.).
  • William Moore
    Department of Radiology (M.K., W.M., K.F., J.S.B., G.M., J.P.K.), Department of Medicine, Division of Hematology and Medical Oncology, Laura and Isaac Perlmutter Cancer Center (D.K.), and Center for Healthcare Innovation and Delivery Science (L.I.H.), NYU Langone Health, 550 First Ave, New York, NY 10016; Division of Healthcare Delivery Science, Department of Population Health and Division of General Internal Medicine and Clinical Innovation, Department of Medicine, NYU Grossman School of Medicine, New York, NY (L.I.H.); and Garden State Urology, Wayne, NJ (A.K.).
  • Kush Fansiwala
    Department of Radiology (M.K., W.M., K.F., J.S.B., G.M., J.P.K.), Department of Medicine, Division of Hematology and Medical Oncology, Laura and Isaac Perlmutter Cancer Center (D.K.), and Center for Healthcare Innovation and Delivery Science (L.I.H.), NYU Langone Health, 550 First Ave, New York, NY 10016; Division of Healthcare Delivery Science, Department of Population Health and Division of General Internal Medicine and Clinical Innovation, Department of Medicine, NYU Grossman School of Medicine, New York, NY (L.I.H.); and Garden State Urology, Wayne, NJ (A.K.).
  • James S Babb
    Department of Radiology (M.K., W.M., K.F., J.S.B., G.M., J.P.K.), Department of Medicine, Division of Hematology and Medical Oncology, Laura and Isaac Perlmutter Cancer Center (D.K.), and Center for Healthcare Innovation and Delivery Science (L.I.H.), NYU Langone Health, 550 First Ave, New York, NY 10016; Division of Healthcare Delivery Science, Department of Population Health and Division of General Internal Medicine and Clinical Innovation, Department of Medicine, NYU Grossman School of Medicine, New York, NY (L.I.H.); and Garden State Urology, Wayne, NJ (A.K.).
  • David Kaminetzky
    Department of Radiology (M.K., W.M., K.F., J.S.B., G.M., J.P.K.), Department of Medicine, Division of Hematology and Medical Oncology, Laura and Isaac Perlmutter Cancer Center (D.K.), and Center for Healthcare Innovation and Delivery Science (L.I.H.), NYU Langone Health, 550 First Ave, New York, NY 10016; Division of Healthcare Delivery Science, Department of Population Health and Division of General Internal Medicine and Clinical Innovation, Department of Medicine, NYU Grossman School of Medicine, New York, NY (L.I.H.); and Garden State Urology, Wayne, NJ (A.K.).
  • Leora I Horwitz
    Department of Radiology (M.K., W.M., K.F., J.S.B., G.M., J.P.K.), Department of Medicine, Division of Hematology and Medical Oncology, Laura and Isaac Perlmutter Cancer Center (D.K.), and Center for Healthcare Innovation and Delivery Science (L.I.H.), NYU Langone Health, 550 First Ave, New York, NY 10016; Division of Healthcare Delivery Science, Department of Population Health and Division of General Internal Medicine and Clinical Innovation, Department of Medicine, NYU Grossman School of Medicine, New York, NY (L.I.H.); and Garden State Urology, Wayne, NJ (A.K.).
  • Georgeann McGuinness
    Department of Radiology (M.K., W.M., K.F., J.S.B., G.M., J.P.K.), Department of Medicine, Division of Hematology and Medical Oncology, Laura and Isaac Perlmutter Cancer Center (D.K.), and Center for Healthcare Innovation and Delivery Science (L.I.H.), NYU Langone Health, 550 First Ave, New York, NY 10016; Division of Healthcare Delivery Science, Department of Population Health and Division of General Internal Medicine and Clinical Innovation, Department of Medicine, NYU Grossman School of Medicine, New York, NY (L.I.H.); and Garden State Urology, Wayne, NJ (A.K.).
  • Abraham Knoll
    Department of Radiology (M.K., W.M., K.F., J.S.B., G.M., J.P.K.), Department of Medicine, Division of Hematology and Medical Oncology, Laura and Isaac Perlmutter Cancer Center (D.K.), and Center for Healthcare Innovation and Delivery Science (L.I.H.), NYU Langone Health, 550 First Ave, New York, NY 10016; Division of Healthcare Delivery Science, Department of Population Health and Division of General Internal Medicine and Clinical Innovation, Department of Medicine, NYU Grossman School of Medicine, New York, NY (L.I.H.); and Garden State Urology, Wayne, NJ (A.K.).
  • Jane P Ko
    Department of Radiology (M.K., W.M., K.F., J.S.B., G.M., J.P.K.), Department of Medicine, Division of Hematology and Medical Oncology, Laura and Isaac Perlmutter Cancer Center (D.K.), and Center for Healthcare Innovation and Delivery Science (L.I.H.), NYU Langone Health, 550 First Ave, New York, NY 10016; Division of Healthcare Delivery Science, Department of Population Health and Division of General Internal Medicine and Clinical Innovation, Department of Medicine, NYU Grossman School of Medicine, New York, NY (L.I.H.); and Garden State Urology, Wayne, NJ (A.K.).

Keywords

No keywords available for this article.